Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
J. De Torres Tajes (Pamplona, Spain), J. Wisnivesky (New York, United States of America), D. Wilson (Pittsburgh , United States of America), C. Casanova (Tenerife, Spain), J. Marin (Zaragoza, Spain), V. Pinto Plata (Springfield, United States of America), M. Divo (Boston, United States of America), F. Polverino (Boston, United States of America), C. Cabrera (Las Palmas, Spain), J. Zulueta (Pamplona, Spain), B. Celli (Boston, United States of America), G. Bastarrika (Pamplona, Spain)
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. De Torres Tajes (Pamplona, Spain), J. Wisnivesky (New York, United States of America), D. Wilson (Pittsburgh , United States of America), C. Casanova (Tenerife, Spain), J. Marin (Zaragoza, Spain), V. Pinto Plata (Springfield, United States of America), M. Divo (Boston, United States of America), F. Polverino (Boston, United States of America), C. Cabrera (Las Palmas, Spain), J. Zulueta (Pamplona, Spain), B. Celli (Boston, United States of America), G. Bastarrika (Pamplona, Spain). Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.. 3626
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 Source: Eur Respir J, 53 (5) 1900164; 10.1183/13993003.00164-2019 Year: 2019
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Source: Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017 Year: 2017
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time Source: Eur Respir J, 50 (1) 1700671; 10.1183/13993003.00671-2017 Year: 2017
Tuberculosis associated Obstructive Lung disease- A Pilot Study Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021
Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019
The Burden of Asymptomatic Lung Cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
The Czech National Programme for Early Detection of Chronic Obstructive Pulmonary Disease – interim results from the pivotal project. Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation? Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019
Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease Source: Guideline 2019 Year: 2019
Incident Depression in Patients with Chronic Obstructive Pulmonary Disease: a UK Population-based Study Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care Year: 2020
Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD Source: Eur Respir J 2014; 44: 1177-1187 Year: 2014
The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction Source: Eur Respir J 2012; 39: 1458-1467 Year: 2012
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021